Important Announcements

Nondiscrimination Statement Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To see our full nondiscrimination statement, click here.

Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

Academic Publications

Select your language:

  • Vasan RS, Massaro JM, Wilson PW, Seshadri S, Wolf PA, Levy D, D'Agostino RB. Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study. Circulation. 2002;105:48-53.
  • Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287:1003-10.
  • Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346: 476-83.
  • Seshadri S, Wolf PA. Homocysteine and dementia - Reply. N Engl J Med 2002; 346: 2008.
  • Tan ZS, Seshadri S, Beiser A, Wilson PW, Keil DP, Tocco M, D'Agostino RB, Wolf PA. Plasma cholesterol level as a risk factor for Alzheimer's disease: the Framingham Study. Arch Intern Med 2003; 163:1053-7.
  • Elias MF, Sullivan LM, D'Agostino RB, Elias PK, Beiser A, Au R, Seshadri S, DeCarli C, Wolf PA. Framingham stroke risk profile and lowered cognitive performance. Stroke 2004;35: 404-409.
  • Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Dementia after stroke: the Framingham Study. Stroke 2004;35:1264-69.
  • Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004;35:1857-61.
  • Seshadri S, Wolf PA, Besier A, Elias MF, Au R, Kase CS, D'Agostino RB, DeCarli C. Stroke risk profile, brain volume and cognitive function: the Framingham Offspring Study. Neurology 2004;63:1591-99.
  • Seshadri S, Beiser A, Ivan CS, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Does preventing stroke prevent all kinds of dementia? Response. Stroke 2004;35: 2437.
  • Au R, Seshadri S, Wolf PA, Sullivan L, D'Agostino RB. New norms for a new generation: cognitive performance in the Framingham
  • Offspring Cohort. Experimental Aging Research 2004;30:333-358.
  • Tan ZS, Seshadri S, Beiser A, et al. Bone mineral disease and the risk of Alzheimer's disease. Arch Neurol 2005;62:107-111.
  • Ellias MF, Sullivan LM, D'Agostino RB, Elias PK, Jacques PF, Selhub J, Seshadri S, Au R, Beiser A, Wolf PA. Homocysteine and cognitive performance in the Framingham Offspring Study: age is important. Am J Epidemiol 2005;162:644-53.
  • Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, Wolf PA. Temporal trends in incidence, lifetime risk, severity and mortality of stroke over the past fifty years. JAMA 2006;296:2939-46.
  • Das RR, Seshadri S, Beiser AS, Himali JJ, Au R, Kelly-Hayes M, Kase CS, Benjamin EJ, Polak JF, O'Donnell CJ, D'Agostino RB, DeCarli C, Wolf PA. Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring. Stroke 2008 [in press].

Abstracts presented at national and international meetings in last 5 years, not yet published

  • Auerbach SH, Au R, Beiser A, Seshadri S, Wolf PA. Mild cognitive impairment: 25 year follow-up in the Framingham Study. Neurology 2003; 60 (Suppl 1): A244.
  • Najarian R, Seshadri S, Beiser A, Au R, Wolf PA. Blood pressure, weight loss and Alzheimer's disease: insights from the Framingham Study. Neurology 2003;60 (Suppl 1):A207.
  • Seshadri S, Beiser A, Vasan RS, DeCarli C, Wang TJ, Au R, Larson MG, Levy D, Wolf PA. Association of plasma atrial and B-type natriuretic peptides in silent cerebral infarcts and white matter hyperintensity on brain magnetic resonance imaging. Stroke 2004;35:314.
  • Romero JR, Seshadri S, Beiser A, DeCarli C, Au R, Ramachandran V, Wolf PA. Matrix metalloproteinases are associated with MRI indices of brain ischemia and aging: the Framingham Study. Neurology 2006;66 (Suppl2):A318.
  • Albert M, Au R, Massaro JM, Seshadri S, Wolf PA, DeCarli C. Sex differences on brain MRI and cognition in Framingham Offspring Study. Neurology 2007;68;(Suppl 1):A168.
  • Pikula A, Böger RH, Beiser A, Maas R, DeCarli C, Schwedhelm E, Du Y, Schulze F, Au R, Kelly-Hayes M, Kase CS, Vasan RS, Wolf PA, Seshadri S. Plasma asymmetric dimethylarginine levels are associated with silent cerebral infarcts: the Framingham Study. Platform presentation at 60th AAN Annual Meeting in Chicago, IL. Neurology April, 2008.
  • Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Stroke in Women - Gender Differences in Stroke Incidence and Post-stroke Disability in the Framingham Heart Study. Stroke Feb. 2008;39:551.